Serum proteomic profiles suggest celecoxib-modulated targets and response predictors.
Xiao Z, Luke BT, Izmirlian G, Umar A, Lynch PM, Phillips RK, Patterson S, Conrads TP, Veenstra TD, Greenwald P, Hawk ET, Ali IU.
Xiao Z, et al. Among authors: veenstra td.
Cancer Res. 2004 Apr 15;64(8):2904-9. doi: 10.1158/0008-5472.can-03-3754.
Cancer Res. 2004.
PMID: 15087410